| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Ilsung Is Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩15,910.00 |
| 52 Week High | ₩29,000.00 |
| 52 Week Low | ₩15,300.00 |
| Beta | -0.24 |
| 11 Month Change | -1.97% |
| 3 Month Change | -3.46% |
| 1 Year Change | -20.45% |
| 33 Year Change | 6.21% |
| 5 Year Change | -4.62% |
| Change since IPO | 946.72% |
Recent News & Updates
Recent updates
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Feb 20
Ilsung Pharmaceuticals (KRX:003120) Is Growing Earnings But Are They A Good Guide?
Jan 16Here's What Ilsung Pharmaceuticals Co., Ltd.'s (KRX:003120) Shareholder Ownership Structure Looks Like
Dec 18
Reflecting on Ilsung Pharmaceuticals' (KRX:003120) Share Price Returns Over The Last Three Years
Nov 21Shareholder Returns
| A003120 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.8% | -2.7% | -0.01% |
| 1Y | -20.5% | 20.4% | 3.0% |
Return vs Industry: A003120 underperformed the KR Pharmaceuticals industry which returned 20.4% over the past year.
Return vs Market: A003120 underperformed the KR Market which returned 3% over the past year.
Price Volatility
| A003120 volatility | |
|---|---|
| A003120 Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.6% |
Stable Share Price: A003120 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A003120's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | n/a | Seok-geun Yoon | www.ilsung-ph.co.kr |
Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular system products. The company was formerly known as Ilsung Pharmaceuticals Co., Ltd.
Ilsung Is Co., Ltd. Fundamentals Summary
| A003120 fundamental statistics | |
|---|---|
| Market cap | ₩110.88b |
| Earnings (TTM) | -₩20.18b |
| Revenue (TTM) | ₩73.22b |
1.5x
P/S Ratio-5.5x
P/E RatioIs A003120 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003120 income statement (TTM) | |
|---|---|
| Revenue | ₩73.22b |
| Cost of Revenue | ₩44.31b |
| Gross Profit | ₩28.91b |
| Other Expenses | ₩49.10b |
| Earnings | -₩20.18b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.90k |
| Gross Margin | 39.49% |
| Net Profit Margin | -27.56% |
| Debt/Equity Ratio | 0% |
How did A003120 perform over the long term?
See historical performance and comparison